Sign in
BHST Stock Price, Chart, Stats & News
BioHarvest Sciences Inc. Common Stock
Save
50.42M
Market cap
–
Current P/E
153.85x
Forward P/E
BHST chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 59.21% |
Operating margin | -18.77% |
Pretax margin | -35.88% |
Net margin | -36.33% |
Effective tax rate | -1.26% |
ROA | -33.78% |
ROE | -1198.89% |
D/E | 2.57x |
Interest coverage ratio | -1.10x |
BHST valuation
P/E | – |
P/S | 2.30x |
P/B | 9.73x |
P/CF | -9.41x |
P/FCF | -7.47x |
P/OCF | -9.41x |
PEG | -2.22x |
EV multiple | -14.39x |
About
BioHarvest Sciences Inc. functions as a biotechnology firm with operations segmented into Nutraceuticals and Pharmaceuticals. A key innovation is its proprietary botanical synthesis platform technology, which allows for the cultivation of active ingredients found within plant enzymes or cells. The company harnesses this advanced technology to craft evidence-based and clinically validated therapeutic products for both its nutraceutical and pharmaceutical offerings.
Similar securities
Based on sector and market capitalization
Report issue